Refine by
Parenterals Articles & Analysis
17 news found
PDA today announced the establishment of the Jette Christensen Early Career Professional Grant in memory of the Immediate-Past Chair of the PDA Board of Directors, who passed away on October 24 after a long battle with cancer. As a PDA member, Board Member, and PDA Chair, Jette’s dedication to PDA’s mission of advancing pharmaceutical/biopharmaceutical manufacturing science and ...
Excipients for Injections & Sterile Formulation For injections and sterile formulations, CD Formulation provides excipients that maintain the sterility and stability of parenteral products. Commonly used excipients for injections and sterile formulations mainly include antioxidants, chelating agents, emulsifiers, suspending agents, lyophilization reagents, osmotic pressure ...
Xarelto is approved for more venous and arterial thromboembolic (VAT) conditions than any other NOAC: The prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (AF) with one or more risk factors The treatment of pulmonary embolism (PE) in adults The treatment of deep vein thrombosis (DVT) in adults The prevention of recurrent PE and/or DVT in ...
ByBayer AG
At present, three major types of Increased Bioavailability Excipients can help improve bioavailability. Carbohydrate-based parenteral excipients, such as trehalose, sucrose, mannitol, sorbitol, and maltose. ...
These osmotic pressure regulators will help parenteral preparations to keep isotonic with human plasma. With advanced production equipment and rich management experience, CD Formulation has become the first choice for pharmaceutical companies to synthesize osmotic pressure regulators with different specifications and quality requirements as well as produce corresponding products ...
Liquid dosage forms are administered by oral and parenteral (injection, inhalation, ophthalmology, ear canal, nasal cavity and topical) routes. Oral liquids are non-sterile, while liquids administered by parenteral routes are available in sterile and non-sterile formulations,” says a senior scientist from CD Formulation. ...
Xarelto is approved for more venous and arterial thromboembolic (VAT) conditions than any other NOAC: The prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (AF) with one or more risk factors The treatment of pulmonary embolism (PE) in adults The treatment of deep vein thrombosis (DVT) in adults The prevention of recurrent PE and/or DVT in ...
ByBayer AG
People can take glucosamine hydrochloride by mouth to treat osteoarthritis, rheumatoid arthritis, glaucoma, jaw disease called temporomandibular joint disorder (TMD), joint pain, back pain, and weight loss.Specifically, glucosamine hydrochloride is often used together with chondroitin sulfate, shark cartilage and camphor to treat osteoarthritis skin. And it is used parenterally ...
The most prominent virulence factors associated with S. aureus are staphylococcal enterotoxins (SEs), which cause toxic shock-like syndrome and are associated with food poisoning. SEs are potent parenteral toxins synthesized by Staphylococcus aureus throughout the logarithmic growth phase or during the transition from exponential to stationary phase. ...
Classification of Increased Bioavailability Excipients Carbohydrate Carbohydrate-based parenteral excipients, such as trehalose, sucrose, mannitol, sorbitol and maltose, enable formulation scientists to stabilize large and small molecule injection therapies. ...
We strive to enhance convenience and safety of parenteral drug delivery and compliance to therapeutic regimen with innovative, reliable and cost effective wearable medical devices and customized solutions that feature Mechatronics at their core. ...
Enalare Therapeutics Inc., a biopharmaceutical company dedicated to developing novel therapies for patients suffering from life-threatening critical care conditions, announced today that it has filed a Provisional Patent Application with the United States Patent and Trademark Office directed to parenteral formulations of ENA-001 and related compounds. The patent application ...
Food and Drug Administration (FDA) has approved two pediatric indications for Xarelto (rivaroxaban): the treatment of venous thromboembolism (VTE) and reduction in the risk of recurrent VTE in patients from birth to less than 18 years after at least five days of initial parenteral (injected or intravenous) anticoagulant treatment; and thromboprophylaxis (prevention of VTE and VTE ...
ByBayer AG
Liquid dosage forms are administered by oral and parenteral (injection, inhalation, ophthalmology, ear canal, nasal cavity and topical) routes. Oral liquids are non-sterile, while liquids administered by parenteral routes are available in sterile and non-sterile formulations,” says a senior scientist from CD Formulation. ...
Jacqueline has an extensive career in Quality leadership, and currently serves as Regulatory and Quality Advisory Board Chair for the Parenteral Drug Association (PDA). Jackie will maintain leadership of our Global Quality Leadership Team and will continue to drive forward the globalization of our Quality Management Systems. ...
Major advantages of the V-Smart™ nanovesicles include: penetrability through BBB without barrier disruption, specific targeting, selective release at target sites, high encapsulation capacity (e.g., small molecules, peptides, proteins and nucleic acids) without requiring modification of active drug, stability with controlled release mechanisms, oral and parenteral ...
CNN recently reported that nineteen patients in six Alabama hospitals became infected with the bacterium Serratia marcescens after receiving contaminated intravenous total parenteral nutrition (TPN). Nine of the 19 patients have died. Investigators are working to determine if the infection from the bacterium found inside the IV bags of TPN solution is directly responsible for ...